Glucose/fructose/phosphoric acid
(Redirected from Emetrol)
.jpg) | |
| Combination of | |
|---|---|
| Glucose | Monosaccharide |
| Fructose | Monosaccharide |
| Phosphoric acid | Acid |
| Clinical data | |
| Trade names | Emetrol |
| AHFS/Drugs.com | Consumer Drug Information |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
Glucose/fructose/phosphoric acid (trade name Emetrol) is an over-the-counter antiemetic taken to relieve nausea and vomiting. Made by WellSpring Pharmaceutical Corporation, it was formerly distributed by McNeil Consumer Healthcare.
History
[edit]Emetrol was created by Kinney and Company of Columbus, Indiana and was first used in 1949.[1]
It is a phosphorated carbohydrate solution, and comes in syrup form.
Contraindications
[edit]Since Emetrol contains fructose it is contraindicated for people with hereditary fructose intolerance (HFI). In diabetes patients, it can cause potentially harmful hyperglycaemia (high blood sugar).[2]
References
[edit]- ^ "History of Emetrol, a Classic American Remedy for Nausea". Archived from the original on 2011-03-05.
- ^ Consumer Drug Information
External links
[edit] | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |